MedTrace Logo

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients

NCT05437003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 465

Last updated 2024-02-16

No results posted yet for this study

Summary

This is a prospective study in a cohort of about 500 patients with Idiopathic Parkinson's disease, examined routinely in the neurological outpatient clinic.

This study aims to evaluate the correlation between oculometric measures and clinical endpoints. Subjects will be evaluated following a physician examination.The evaluations will include MDS-UPDRS examination, as well as an oculometric evaluation for eye movements. In addition, 500 healthy subjects will be evaluated.

Conditions

  • Idiopathic Parkinson Disease

Interventions

OTHER

NeuraLight software-based platform

NeuraLight is an investigational software-based platform that is used for assessment and evaluation of neurological conditions including PD patients

Sponsors & Collaborators

  • NeuraLight

    lead INDUSTRY

Principal Investigators

  • Johnathan Reiner, MD · Sackler Faculty of Medicine, Tel Aviv University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-20
Primary Completion
2024-02-15
Completion
2024-02-15

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05437003 on ClinicalTrials.gov